Safety and Operative Burden of Immediate Lymphatic Reconstruction During Breast Cancer Surgery With Concurrent Breast Reconstruction: A 13‐Year ACS‐NSQIP Analysis
Microsurgery · 2026-12 · 46 (8)
DOI: 10.1002/micr.70327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microsurgery, online erschienen am 08.11.2026. Verfasst von Georgios Karamitros und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Mammaplasty, Breast Neoplasms, Postoperative Complications, Mastectomy. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Immediate lymphatic reconstruction (ILR) is increasingly performed during axillary lymph node dissection to reduce breast cancer‐related lymphedema. Prior national studies evaluated broader ALND populations, while the perioperative safety and operative‐duration profile of ILR specifically during concurrent breast reconstruction remains incompletely defined. We evaluated 30‐day safety and total operative duration associated with ILR in women undergoing breast cancer surgery with concurrent reconstruction.
Methods
We performed a retrospective cohort study using ACS‐NSQIP data from 2012 to 2024. Adult women with breast malignancy undergoing breast extirpative surgery with same‐encounter implant‐based or autologous reconstruction were included. ILR was identified using a published CPT‐based algorithm. The primary outcome was any 30‐day postoperative complication. Secondary outcomes included wound complications, surgical‐site infection (SSI), return to the operating room, readmission, operative time, and length of stay. Temporal efficiency was assessed using an ILR‐by‐year interaction.
Results
Among 65,437 women, 367 (0.56%) underwent ILR. Use increased from 0.03% in 2012 to 1.57% in 2024. Documented ALND was present in 72.2% of ILR recipients and 18.7% of nonrecipients. ILR was not associated with any 30‐day complication (adjusted odds ratio [aOR] = 0.98; 95% CI = 0.71–1.35; p = 0.898), wound complications (aOR = 1.11; 95% CI = 0.75–1.65; p = 0.597), SSI (aOR = 0.88; 95% CI = 0.56–1.40; p = 0.600), return to the operating room (aOR = 0.92; 95% CI = 0.62–1.37; p = 0.681), or readmission (aOR = 1.05; 95% CI = 0.65–1.70; p = 0.834). ILR was associated with a 90.4‐min longer total operative duration (95% CI = 80.1–100.6; p < 0.001), without a difference in postoperative length of stay (adjusted mean difference, 0.03 days; 95% CI = −0.21 to 0.26; p = 0.832). The operative‐duration difference did not attenuate over time (interaction = 0.44 min/year; 95% CI = −2.89 to 3.78; p = 0.796).
Conclusions
ILR was not associated with increased adjusted 30‐day morbidity but was associated with longer total operative duration. These findings support short‐term perioperative safety in patients undergoing concurrent reconstruction but do not establish long‐term effectiveness in preventing breast cancer‐related lymphedema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Surgery, College of Medicine, State University of New York, Downstate Health Sciences University, Brooklyn, New York, USA.
- Division of Plastic and Reconstructive Surgery, University of Maryland Medical Center, Baltimore, Maryland, USA.
- Division of Plastic and Reconstructive Surgery, Rush University Medical Center, Chicago, Illinois, USA.
- Department of Plastic Surgery, The Ohio State University, Columbus, Ohio, USA.
- Division of Plastic and Reconstructive Surgery, R. Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, Maryland, USA.
ORCID-Profile: Georgios Karamitros, Georgios Bouloukakis, George Kokosis, Gregory A Lamaris
Zitieren
APA
Karamitros, G., Bouloukakis, G., Perdikis, G., Rasko, Y. M., Kokosis, G., Skoracki, R., & Lamaris, G. A. (2026). Safety and Operative Burden of Immediate Lymphatic Reconstruction During Breast Cancer Surgery With Concurrent Breast Reconstruction: A 13‐Year ACS‐NSQIP Analysis. Microsurgery, 46(8). https://doi.org/10.1002/micr.70327
Vancouver
Karamitros G, Bouloukakis G, Perdikis G, Rasko YM, Kokosis G, Skoracki R, et al. Safety and Operative Burden of Immediate Lymphatic Reconstruction During Breast Cancer Surgery With Concurrent Breast Reconstruction: A 13‐Year ACS‐NSQIP Analysis. Microsurgery. 2026;46(8). doi:10.1002/micr.70327
BibTeX
@article{Karamitros2026,
author = {Karamitros, Georgios and Bouloukakis, Georgios and Perdikis, Galen and Rasko, Yvonne M and Kokosis, George and Skoracki, Roman and Lamaris, Gregory A},
title = {Safety and Operative Burden of Immediate Lymphatic Reconstruction During Breast Cancer Surgery With Concurrent Breast Reconstruction: A 13‐Year ACS‐NSQIP Analysis},
journal = {Microsurgery},
year = {2026},
volume = {46},
number = {8},
doi = {10.1002/micr.70327}
}
EUVIMED